Financial Gravity Asset Management, Inc. Meridian Bioscience Inc Transaction History

Financial Gravity Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$23.75 - $31.69 $12,825 - $17,112	540 New	540 $2.67 Million
Q2 2021 Aug 11, 2021	SELL	$18.01 - $28.32 $2,593 - $4,078	-144 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $829 - $1,255	42 Added 41.18%	144 $3.77 Million
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $1,604 - $2,209	102 New	102 $1,000
Q4 2019 Feb 28, 2020	SELL	$7.9 - $10.14 $5,356 - $6,874	-678 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$9.17 - $12.01 $16,166 - $21,173	-1,763 Reduced 72.22%	678 $6,000
Q2 2019 Jul 26, 2019	BUY	$10.88 - $17.6 $26,558 - $42,961	2,441 New	2,441 $29,000
Q1 2019 Apr 19, 2019	SELL	$15.51 - $17.61 $1,566 - $1,778	-101 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$14.85 - $16.35 $5,049 - $5,559	-340 Reduced 77.1%	101 $2,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $3,146 - $3,830	228 Added 107.04%	441 $7,000
Q1 2018 May 23, 2018	BUY	$13.8 - $16.2 $2,939 - $3,450	213 New	213 $3,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.